Ferring would like to use cookies to better understand your use of this website and improve your experience while navigating it. Please accept our use of cookies in accordance with our privacy policy

Accept / Decline

Press releases

Ferring Pharmaceuticals Announces Board Changes

Saint Prex, Switzerland, September 25, 2007 - Ferring Pharmaceuticals today announced changes to the company's Board of Directors.  Effective immediately, Alexandra, Countess of Frederiksborg will become a new non-executive member of the Board.  The Countess (formerly Princess Alexandra of Denmark) has a career background in marketing and is involved in philanthropic pursuits as Patron for UNICEF Denmark and the Danish Society for the Blind.  As Patron for UNICEF the Countess has traveled to Thailand and among others visited HIV/AIDS patients.

Frederik Paulsen, Chairman and Chief Executive Officer of Ferring Pharmaceuticals commented, "We are very pleased that Countess Alexandra will be joining our Board of Directors.  Her combined business education, marketing career and philanthropic experience will be very valuable for Ferring in the application of business ethics and the further development of our corporate social responsibility activity and company philosophy".

At the same time Ferring announces the retirement from the Board of Dr. John McGuire. John McGuire joined Ferring in 2004 both as President of its Research Institute and as a member of the Board of Directors. He has decided to step down from the Board for health reasons.

Frederik Paulsen added, "Whilst we are sad to announce the departure of Dr. John McGuire. I would like to thank him for his contribution to Ferring over the past few years and to wish him the very best in his retirement."

Hélène Ploix and Dr. Bernd Wolff continue in their roles as Directors on the Board, and Jeffrey D. Hobbs continues in his role as Vice Chairman.


About Ferring
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of endocrinology, gastroenterology, gynaecology and obstetrics, fertility and urology.
In recent years Ferring has expanded beyond its traditional European base and now has operating subsidiaries in over 40 countries. To learn more about Ferring or our products please visit www.ferring.com.

For further information, please contact:
Helen Gallagher or Michael George
Corporate Communications
t: +41 58 301 0051/+41 58 301 0053
E: helen.gallagher@ferring.com or michael.george@ferring.com

See more Press releases



TEL:  +41 58 301 00 00
FAX: +41 58 301 00 10


Global Locator